Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Amendment to Performance Share Plan

14 Dec 2022 10:45

RNS Number : 6814J
DX (Group) PLC
14 December 2022
 

AIM: DX.

DX (Group) plc

("DX" or "the Group" or "the Company")

 

Company Performance Share Plan

 

DX, the provider of delivery solutions, including parcel freight, secure courier and logistics services, reports an amendment ("Amendment") to the Performance Condition of the Company's Performance Share Plan ("PSP"), which was established in December 2017 for directors and certain senior management of the Company ("Participants").

 

The Amendment introduces a further testing date of 21 December 2023, with the objective of retaining and fairly rewarding the 36 Participants, who are currently employed by the Group, in the PSP for a further year. The current third and final testing date for the PSP is on 21 December 2022 and the Amendment therefore extends the Performance Condition and adds a further measurement date in twelve months' time.

 

In light of the close proximity of the date of restoration of the Company's ordinary shares to trading on 19 October 2022 and the third testing date for the PSP under the plan on 21 December 2022, the Amendment creates additional time for the continued strong trading by the Group and its positive outlook to be recognised in a fair market price.

 

The Amendment also provides the further benefit of enabling DX to defer the implementation of a replacement Long Term Incentive Plan for a year and will help to retain and motivate the senior managers in the PSP.

 

A majority of shareholders of the Company's issued share capital, were consulted with respect to the Amendment.

 

Related party transaction

 

Under the AIM Rules for Companies, the Amendment to the PSP in relation to David Mulligan, Paul Ibbetson, Martin Illidge, Michael Sherry, and Kevin Galligan is classified as a Related Party Transaction. Accordingly, Mark Hammond, Mike Russell and Jon Kempster as Independent Directors consider, having consulted with finnCap, the Company's Nominated Adviser, that the terms of the Amendment are fair and reasonable insofar as its shareholders are concerned.

 

Enquiries:

DX (Group) plc

T: 020 3178 6378 (c/o KTZ

Jon Kempster, Senior Independent Non-executive Director

 Communications)

Mike Russell, Independent Non-executive Director

finnCap (Nominated Adviser & Joint Broker to DX)

T: 020 7220 0500

Matt Goode/Simon Hicks (Corporate Finance)

Andrew Burdis/Charlotte Sutcliffe (ECM)

 

Liberum (Joint Broker to DX)

T: 020 3100 2000

Nick How/William Hall

 

 

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis

Dan Mahoney

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANALFELAFEA
Date   Source Headline
13th Sep 202311:39 amRNSForm 8.3 - DX Group PLC
13th Sep 202310:31 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
13th Sep 20239:35 amRNSForm 8.5 (EPT/RI)
13th Sep 20237:44 amRNSForm 8.5 (EPT/RI)
12th Sep 20234:47 pmGNWForm 8.3 - DX (Group) plc
12th Sep 20234:42 pmRNSForm 8.3 - DX Group Plc
12th Sep 20234:08 pmRNSForm 8.3 - DX Group Plc
12th Sep 20233:56 pmRNSForm 8.5 (EPT/RI)
12th Sep 20232:09 pmRNSForm 8.3 - DX Group PLC
12th Sep 20232:02 pmGNWForm 8.3 - [DX (Group) plc - Opening Declaration - 11 09 2023] - (CGAML)
12th Sep 202312:20 pmRNSForm 8.3 - DX Group PLC
12th Sep 202312:03 pmRNSGatemore supports offer from HIG for DX Group
12th Sep 20239:37 amRNSPOSSIBLE OFFER FOR DX GROUP PLC
12th Sep 20239:24 amRNSForm 8.5 (EPT/RI)
12th Sep 20239:10 amPRNForm 8.3 - DX (Group) plc
12th Sep 20239:05 amRNSForm 8.5 (EPT/RI)
11th Sep 20232:36 pmRNSPossible Offer
11th Sep 20237:00 amRNSOpening of new regional hub in Haydock
21st Aug 20237:00 amRNSNew Depot Opening in Norwich
14th Aug 20237:00 amRNSAppointment of Joint Broker
9th Aug 20234:25 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSFirst former Tuffnells site opened
3rd Aug 20232:07 pmRNSIssue of Equity and Total Voting Rights
18th Jul 20237:00 amRNSTrading Update
11th Jul 20237:00 amRNSOpening of Deeside Depot
29th Jun 20237:00 amRNSAgreement regarding Tuffnells sites
28th Jun 20237:00 amRNSMajor investment in electric vehicles
14th Jun 20237:00 amRNSDevelopment of a New Regional Hub
7th Jun 20237:00 amRNSSettlement of Claim
18th May 20237:00 amRNSHolding(s) in Company
12th May 20237:00 amRNSChange of Adviser
24th Apr 20237:00 amRNSExpansion of Depot Network
6th Apr 202312:29 pmRNSGrant of share award and PDMR notification
3rd Apr 20234:25 pmRNSGrant of SAYE Options
27th Mar 20237:00 amRNSNew hub and new depot opened
13th Mar 20237:00 amRNSNew Depot Openings
8th Mar 20238:03 amRNSGrant of share awards and PDMR shareholding
27th Feb 20237:00 amRNSInterim Results
13th Feb 20237:00 amRNSNotice of Interim Results
13th Feb 20237:00 amRNSResponse to media article
9th Feb 20238:00 amRNSDX Freight Appointments
7th Feb 20232:12 pmRNSIssue of Equity and Total Voting Rights
31st Jan 202311:41 amRNSHolding(s) in Company
31st Jan 20237:00 amRNSAppointment of CEO
31st Jan 20237:00 amRNSTrading Update
18th Jan 20238:07 amRNSTR1 Notification
13th Jan 20232:49 pmRNSHolding(s) in Company
12th Jan 20232:25 pmRNSIssue of Equity and Total Voting Rights
6th Jan 20238:00 amRNSDirector/PDMR Shareholdings
15th Dec 202210:36 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.